Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  News  >  Companies

News : Latest News
Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors

Babson Diagnostics : Appoints Former Siemens Healthineers Executive to CEO

share with twitter share with LinkedIn share with facebook
09/24/2020 | 09:33am EDT

  • Transformative diagnostics company expands leadership team as it enters commercialization phase
  • Founder and former CEO Eric Olson to assume roles as chairman and COO

Babson Diagnostics (Babson), a transformative medical technology company, has appointed David Stein, Ph.D., former head of global strategy and innovation at Siemens Healthineers, to chief executive officer. Eric Olson, Babson’s founder and former CEO, will assume the roles of chairman of the board and chief operating officer.

Dr. Stein—who holds a doctorate in engineering from Johns Hopkins University—also serves as a board member for Babson. His prior roles include head of strategy and innovation for Siemens Healthineers, CEO of Siemens' point of care businesses, and global vice president of engineering within Siemens’ diagnostics division. Dr. Stein was instrumental in incubating Babson in the company’s earliest days.

“David and I have worked together for 20 years, and when he became available, the timing was perfect to expand the management team and take Babson into the next phase of growth,” Olson said. “I’ve known David personally and professionally for most of my career. I know what he can achieve and I trust he’ll achieve it with integrity. His expertise in leading business development on behalf of the world’s leading medical technology companies will prove invaluable to Babson as we work to transform the diagnostics industry.”

The announcement follows the company’s recent closing of its $13.7 million Series A funding. The funding raise and expansion of the company’s management team enable Babson to build upon its strategic partnerships, proprietary technology ecosystems, and clinical study programs underway with key retail partners.

Olson will continue to lead Babson’s operations, technology, and clinical affairs, while Dr. Stein will lead the formation of the company’s commercialization, marketing, and business development teams.

“Eric and the Babson Diagnostics team have built a truly unique diagnostics model underpinned by the world’s leaders in health care innovation,” Dr. Stein said. “The broad interest in Babson’s recent Series A funding exemplifies the demand to redefine in-vitro diagnostic testing and will be critical in supporting Babson Diagnostics' mission to fundamentally change how samples are collected, processed and analyzed. It’s an honor to join the core team to bring Eric’s vision to life.”

To learn more about Babson, visit www.babsondx.com.

About Babson Diagnostics

Babson Diagnostics aims to democratize diagnostic blood testing by making it easier, faster, and more pleasant for customers to routinely monitor and improve their health. Babson's proprietary technological ecosystem is designed to deliver accurate diagnostic results with a more human experience. Based in Austin, Texas, its vision for diagnostic blood testing—built on accuracy, convenience, and accessibility—combines transformative diagnostic technology with a customer-first, retail-centric business model that aims to improve customer health and experience. Prior to commercialization, Babson Diagnostics is working with retail pharmacies to validate its technology by conducting clinical studies intended for peer-reviewed publication. For more information on Babson Diagnostics, please visit www.babsondx.com.

© Business Wire 2020

share with twitter share with LinkedIn share with facebook
Latest news "Companies"
06:37pDUKE ENERGY : restores power to nearly 90% of Carolinas customers who lost electricity due to Tropical Storm Zeta
PR
06:30pTACTILE TECHNOLOGY : ROSEN, TOP RANKED INVESTOR COUNSEL, Reminds Tactile Systems Technology, Inc. Investors of Important November 30 Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact Firm - TCMD
PR
06:25p6 P.M. UPDATE : Georgia Power working to restore remaining 55,000 customers after Hurricane Zeta
PR
06:20pNIKOLA : ROSEN, GLOBAL INVESTOR COUNSEL, Reminds Nikola Corporation Investors of Important November 16 Deadline in First Filed Securities Class Action Commenced by the Firm; Encourages Investors with Losses in Excess of $500K to Contact the Firm - NKLA, NKLAW, VTIQ, VTIQW, VTIQU
PR
06:15pMemorandum on Protecting Jobs, Economic Opportunities, and National Security for All Americans
PU
06:15pPresident Donald J. Trump Is Supporting Hydraulic Fracturing and Other Technologies to Protect Our Jobs, Economic Opportunity, and National Security
PU
06:15pTHOUGHTFUL BRANDS : Provides Update on Verrian and Announces New CFO
PU
06:15pDUKE ENERGY : restores power to nearly 90% of Carolinas customers who lost electricity due to Tropical Storm Zeta
PU
06:00pNational veteran business development council announces live entertainment for vets night out
GL
05:12pAMAZON COM : drops French Black Friday ad campaign as lockdown starts
RE
Latest news "Companies"